Search Results - "Beraldi, Eliana"
-
1
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)
Published in European urology (01-01-2018)“…Darolutamide (ODM-201) is a novel androgen receptor (AR) antagonist with a chemical structure distinctly different from currently approved AR antagonists that…”
Get full text
Journal Article -
2
Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate Cancer
Published in Cancer research (Chicago, Ill.) (15-05-2013)“…Defining the mechanisms underlying metastatic progression of prostate cancer may lead to insights into how to decrease morbidity and mortality in this disease…”
Get full text
Journal Article -
3
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models
Published in The Journal of clinical investigation (01-02-2020)“…HSP27 is highly expressed in, and supports oncogene addiction of, many cancers. HSP27 phosphorylation is a limiting step for activation of this protein and a…”
Get full text
Journal Article -
4
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth
Published in Clinical cancer research (01-04-2015)“…Enzalutamide (ENZ) is a potent androgen receptor (AR) antagonist with activity in castration-resistant prostate cancer (CRPC); however, progression to…”
Get full text
Journal Article -
5
Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release
Published in Pharmaceutical research (01-03-2020)“…Purpose We describe the preparation of injectable polymeric paste (IPP) formulations for local and sustained release of drugs. Furthermore, we include the…”
Get full text
Journal Article -
6
Cooperative Interactions between Androgen Receptor (AR) and Heat-Shock Protein 27 Facilitate AR Transcriptional Activity
Published in Cancer research (Chicago, Ill.) (01-11-2007)“…Androgen receptor (AR) transactivation is known to enhance prostate cancer cell survival. However, the precise effectors by which the prosurvival effects of…”
Get full text
Journal Article -
7
Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability
Published in Cancer research (Chicago, Ill.) (15-08-2013)“…Although androgen receptor (AR) pathway inhibitors prolong survival in castrate-resistant prostate cancer (CRPC), resistance rapidly develops and is often…”
Get full text
Journal Article -
8
Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells
Published in Molecular cancer therapeutics (01-01-2007)“…Heat shock protein 27 (Hsp27) is a cytoprotective chaperone that is phosphoactivated during cell stress that prevents aggregation and/or regulate activity and…”
Get full text
Journal Article -
9
Hsp27 Promotes Insulin-Like Growth Factor-I Survival Signaling in Prostate Cancer via p90Rsk-Dependent Phosphorylation and Inactivation of BAD
Published in Cancer research (Chicago, Ill.) (15-03-2010)“…Hsp27 is highly expressed in castrate-resistant prostate cancer. Although its overexpression confers resistance to androgen ablation and chemotherapy, the…”
Get full text
Journal Article -
10
Clusterin Inhibition Using OGX-011 Synergistically Enhances Hsp90 Inhibitor Activity by Suppressing the Heat Shock Response in Castrate-Resistant Prostate Cancer
Published in Cancer research (Chicago, Ill.) (01-09-2011)“…Small-molecule inhibitors of Hsp90 show promise in the treatment of castrate-resistant prostate cancer (CRPC); however, these inhibitors trigger a heat shock…”
Get full text
Journal Article -
11
Androgen receptor (AR) antagonism triggers acute succinate‐mediated adaptive responses to reactivate AR signaling
Published in EMBO molecular medicine (07-05-2021)“…Treatment‐induced adaptive pathways converge to support androgen receptor (AR) reactivation and emergence of castration‐resistant prostate cancer (PCa) after…”
Get full text
Journal Article -
12
Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer
Published in Cancer research (Chicago, Ill.) (15-09-2004)“…Heat shock protein 27 (Hsp27) is a chaperone implicated as an independent predictor of clinical outcome in prostate cancer. Our aim was to characterize changes…”
Get full text
Journal Article -
13
Increased Hsp27 after androgen ablation facilitates androgen- independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis
Published in Cancer research (Chicago, Ill.) (01-12-2005)“…One strategy to improve therapies in prostate cancer involves targeting cytoprotective genes activated by androgen withdrawal to delay the emergence of the…”
Get full text
Journal Article -
14
A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinoma
Published in Urologic oncology (01-03-2021)“…•We developed a novel mucoadhesive, polymeric paste formulation of gemcitabine (ST-UC), that can be locally administered via direct instillation to the upper…”
Get full text
Journal Article -
15
Cotargeting stress-activated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress in prostate cancer
Published in Molecular cancer therapeutics (01-08-2012)“…Hsp27 is a stress-activated multifunctional chaperone that inhibits treatment-induced apoptosis and causes treatment resistance in prostate and other cancers…”
Get full text
Journal Article -
16
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
Published in EMBO molecular medicine (01-07-2016)“…Clusterin (CLU) is a stress‐activated molecular chaperone that confers treatment resistance to taxanes when highly expressed. While CLU inhibition potentiates…”
Get full text
Journal Article -
17
A Novel Triazole Nucleoside Suppresses Prostate Cancer Cell Growth by Inhibiting Heat Shock Factor 1 and Androgen Receptor
Published in Anti-cancer agents in medicinal chemistry (01-01-2015)“…A novel triazole nucleoside analogue was discovered to exhibit potent anticancer activity in prostate cancer cells via down-regulating heat shock factor 1…”
Get more information
Journal Article -
18
A polymeric paste-drug formulation for intratumoral treatment of prostate cancer
Published in Prostate cancer and prostatic diseases (01-06-2020)“…Objective Focal therapy has emerged as a treatment option for low- to intermediate-risk localized prostate cancer (PCa) patients, to balance the risks for…”
Get full text
Journal Article -
19
Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer
Published in Molecular cancer research (01-12-2011)“…Clusterin is a stress-activated, cytoprotective chaperone that confers broad-spectrum treatment resistance in cancer. However, the molecular mechanisms…”
Get full text
Journal Article -
20
Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo
Published in Molecular cancer therapeutics (01-02-2011)“…Signal transducer and activator of transcription 5 (Stat5) plays an important role in the transition of prostate cancer (PCa) to its castrate-resistant state…”
Get full text
Journal Article